This nationally representative randomized survey of US adults will evaluate the effect of using brief statements to communicate different sources of uncertainty about the benefits and harms of new cancer drugs on participants' decisions and understanding.
This nationally representative randomized survey of US adults will evaluate the effect of using brief statements to communicate different sources of uncertainty about the benefits and harms of new cancer drugs on participants' decisions and understanding.
Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs
-
Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, United States, 02139
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
Yes
London School of Economics and Political Science,
2025-06